• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Retracted] Silencing the long noncoding RNA, , a molecular sponge of , inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression.[已撤回] 沉默长链非编码RNA,即一种的分子海绵,通过抑制FGF2来抑制上皮性卵巢癌的恶性表型。
Int J Oncol. 2022 Oct;61(4). doi: 10.3892/ijo.2022.5411. Epub 2022 Aug 25.
2
[Retracted] MicroRNA‑511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway.[已撤回] 微小RNA-511通过直接靶向SOX9并调节PI3K/Akt通路来抑制乳腺癌的恶性行为。
Int J Oncol. 2022 Oct;61(4). doi: 10.3892/ijo.2022.5413. Epub 2022 Aug 31.
3
[Retracted] MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.[已撤回]微小RNA‑766通过直接靶向胰岛素受体底物2并调节PI3K/Akt通路来抑制甲状腺乳头状癌进展。
Int J Oncol. 2022 Jul;61(1). doi: 10.3892/ijo.2022.5376. Epub 2022 Jun 1.
4
[Retracted] MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting and deactivating the PI3K/AKT pathway.[已撤回]微小RNA-936通过直接靶向并失活PI3K/AKT通路来抑制视网膜母细胞瘤的恶性表型。
Oncol Rep. 2022 Oct;48(4). doi: 10.3892/or.2022.8389. Epub 2022 Aug 25.
5
[Retracted] MicroRNA-200b inhibits the growth and metastasis of glioma cells via targeting ZEB2.[已撤回] 微小RNA-200b通过靶向锌指E盒结合蛋白2抑制胶质瘤细胞的生长和转移。
Int J Oncol. 2021 Sep;59(3). doi: 10.3892/ijo.2021.5245. Epub 2021 Jul 19.
6
[Retracted] MicroRNA‑664 targets paired box protein 6 to inhibit the oncogenicity of pancreatic ductal adenocarcinoma.[已撤回] 微小RNA-664靶向配对盒蛋白6以抑制胰腺导管腺癌的致癌性。
Int J Oncol. 2022 Aug;61(2). doi: 10.3892/ijo.2022.5380. Epub 2022 Jun 8.
7
[Retracted] MicroRNA‑488 inhibits proliferation, invasion and EMT in osteosarcoma cell lines by targeting aquaporin 3.[已撤回] 微小RNA-488通过靶向水通道蛋白3抑制骨肉瘤细胞系的增殖、侵袭和上皮-间质转化。
Int J Oncol. 2023 Feb;62(2). doi: 10.3892/ijo.2022.5466. Epub 2022 Dec 16.
8
[Retracted] MicroRNA‑873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β‑catenin pathway.[已撤回] 微小RNA-873靶向HOXA9,通过使Wnt/β-连环蛋白信号通路失活来抑制骨肉瘤的侵袭性表型。
Int J Oncol. 2022 Nov;61(5). doi: 10.3892/ijo.2022.5420. Epub 2022 Sep 14.
9
[Retracted] MicroRNA‑432 inhibits the aggressiveness of glioblastoma multiforme by directly targeting IGF‑1R.[已撤回] 微小RNA-432通过直接靶向胰岛素样生长因子-1受体抑制多形性胶质母细胞瘤的侵袭性。
Int J Mol Med. 2022 Nov;50(5). doi: 10.3892/ijmm.2022.5187. Epub 2022 Sep 7.
10
[Retracted] MicroRNA‑202 inhibits cell proliferation, migration and invasion of glioma by directly targeting metadherin.[已撤回] 微小RNA-202通过直接靶向黏附素抑制胶质瘤细胞的增殖、迁移和侵袭。
Oncol Rep. 2022 Jul;48(1). doi: 10.3892/or.2022.8344. Epub 2022 Jun 8.

[已撤回] 沉默长链非编码RNA,即一种的分子海绵,通过抑制FGF2来抑制上皮性卵巢癌的恶性表型。

[Retracted] Silencing the long noncoding RNA, , a molecular sponge of , inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression.

作者信息

Li Rui, Wang Yue, Xu Yuexun, He Xiaoli, Li Yali

机构信息

Department of Obstetrics and Gynecology, Henan Province People's Hospital, The People's Hospital of Zhengzhou University, The People's Hospital of Henan University, Zhengzhou, Henan 450003, P.R. China.

出版信息

Int J Oncol. 2022 Oct;61(4). doi: 10.3892/ijo.2022.5411. Epub 2022 Aug 25.

DOI:10.3892/ijo.2022.5411
PMID:36004482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9477109/
Abstract

Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that various panels showing the data from flow cytometry experiments in Figs. 2C, 4C and 6C, and certain of the tumor images featured in Fig. 9A, were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [International Journal of Oncology 55: 1110‑1124, 2019; DOI: 10.3892/ijo.2019.4875].

摘要

在本文发表后,一位细心的读者提醒编辑注意,图2C、4C和6C中显示流式细胞术实验数据的各个图版,以及图9A中的某些肿瘤图像,与不同作者在其他文章中以不同形式出现的数据惊人地相似。由于上述文章中有争议的数据在提交给本期刊之前已在其他地方发表,或已在考虑发表,编辑决定将本文从该期刊撤回。已要求作者对这些问题作出解释,但编辑部未收到答复。编辑就由此造成的不便向读者表示歉意。[《国际肿瘤学杂志》55: 1110 - 1124, 2019; DOI: 10.3892/ijo.2019.4875]